BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28960612)

  • 21. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.
    Chu WK; Law KS; Chan SO; Yam JC; Chen LJ; Zhang H; Cheung HS; Block NL; Schally AV; Pang CP
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14396-14401. PubMed ID: 27911838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma.
    Yao X; Shen H; Peng Q; Yu J
    Cell Cycle; 2021; 20(5-6):603-615. PubMed ID: 33678118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.
    Di Fiore R; Drago-Ferrante R; D'Anneo A; Augello G; Carlisi D; De Blasio A; Giuliano M; Tesoriere G; Vento R
    Cancer Biol Ther; 2013 Oct; 14(10):922-31. PubMed ID: 23938948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture.
    Albert DM; Nickells RW; Gamm DM; Zimbric ML; Schlamp CL; Lindstrom MJ; Audo I
    Ophthalmic Genet; 2002 Sep; 23(3):137-56. PubMed ID: 12324873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis.
    Delston RB; Matatall KA; Sun Y; Onken MD; Harbour JW
    Oncogene; 2011 Feb; 30(5):588-99. PubMed ID: 20871633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sinomenine Can Inhibit the Growth and Invasion Ability of Retinoblastoma Cell through Regulating PI3K/AKT Signaling Pathway.
    Zheng Q; Zhu Q; Li C; Hao S; Li J; Yu X; Qi D; Pan Y
    Biol Pharm Bull; 2020 Oct; 43(10):1551-1555. PubMed ID: 32759601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells.
    Oronowicz J; Reinhard J; Reinach PS; Ludwiczak S; Luo H; Omar Ba Salem MH; Kraemer MM; Biebermann H; Kakkassery V; Mergler S
    Lab Invest; 2021 Jan; 101(1):70-88. PubMed ID: 32948812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
    Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
    Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulated differentiation of WERI-Rb-1 cells into retinal neuron-like cells.
    Liu Y; Hu H; Liang M; Xiong Y; Li K; Chen M; Fan Z; Kuang X; Deng F; Liu X; Xu C; Li K; Ge J
    Int J Mol Med; 2017 Oct; 40(4):1172-1184. PubMed ID: 28848998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation.
    Shukla S; Gupta S
    Free Radic Biol Med; 2008 May; 44(10):1833-45. PubMed ID: 18342637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyphyllin I Induces Cell Cycle Arrest and Cell Apoptosis in Human Retinoblastoma Y-79 Cells through Targeting p53.
    Zhu X; Wang K; Zhang K; Pan Y; Zhou F; Zhu L
    Anticancer Agents Med Chem; 2018; 18(6):875-881. PubMed ID: 29308745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costunolide Induces Apoptosis through Generation of ROS and Activation of P53 in Human Esophageal Cancer Eca-109 Cells.
    Hua P; Sun M; Zhang G; Zhang Y; Song G; Liu Z; Li X; Zhang X; Li B
    J Biochem Mol Toxicol; 2016 Sep; 30(9):462-9. PubMed ID: 27078502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells.
    Mergler S; Cheng Y; Skosyrski S; Garreis F; Pietrzak P; Kociok N; Dwarakanath A; Reinach PS; Kakkassery V
    Exp Eye Res; 2012 Jan; 94(1):157-73. PubMed ID: 22182671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic fibroblast growth factor impact on retinoblastoma progression and survival.
    Cebulla CM; Jockovich ME; Piña Y; Boutrid H; Alegret A; Kulak A; Hackam AS; Bhattacharya SK; Feuer WJ; Murray TG
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5215-21. PubMed ID: 18614803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
    Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
    Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
    Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
    Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
    J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine induced apoptosis in human retinoblastoma cells.
    Cullinan AE; Brandt CR
    Mol Vis; 2004 Apr; 10():315-22. PubMed ID: 15133451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.
    Kawano T; Akiyama M; Agawa-Ohta M; Mikami-Terao Y; Iwase S; Yanagisawa T; Ida H; Agata N; Yamada H
    Int J Oncol; 2010 Oct; 37(4):787-95. PubMed ID: 20811699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.